Upasana Kachroo

Upasana Kachroo

Auto-generated profile, based on publicly available information

Upasana Kachroo

Department of Physiology, Christian Medical College, Vellore, India

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Acta Histochemica
Verified
Journal Article
Closed access
EVElizabeth Vinod
Elizabeth Vinod
UKUpasana Kachroo
Upasana Kachroo
SASoosai Manickam Amirtham
Soosai Manickam Amirtham
BRBoopalan Ramasamy
Boopalan Ramasamy
SSSolomon Sathishkumar
Solomon Sathishkumar

25 August 2020 in CARTILAGE
Verified
Journal Article
Closed access
PDF file
EVElizabeth Vinod
Elizabeth Vinod
RPRoshni Parameswaran
Roshni Parameswaran
BRBoopalan Ramasamy
Boopalan Ramasamy
UKUpasana Kachroo
Upasana Kachroo
Chondroprogenitors have recently gained prominence due to promising results seen in in vitro and animal studies as a potential contender in cell-based therapy for cartilage repair. Lack of consensus regarding nomenclature, isolation techniques, and expansion protocols create substantial limitations for translational research, especially given the absence of distinct markers of identification. The objective of this systematic review was to identify and collate information pertaining to hyaline cartilage–derived chondroprogenitors, with regard to their isolation, culture, and outcome measures. As per Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a web-based search of Scopus and PubMed databases was performed from January 2000 to May 2020, which yielded 509 studies. A total of 65 studies were identified that met the standardized inclusion criteria which comprised of, but was not limited to, progenitors derived from fibronectin adhesion, migrated subpopulation from explant cultures, and single-cell sorting. Literature search revealed that progenitors demonstrated inherent chondrogenesis and minimal tendency for hypertrophy. Multiple sources also demonstrated significantly better outcomes that bone marrow–derived mesenchymal stem cells and comparable results to chondrocytes. With regard to progenitor subgroups, collated evidence points to better and consistent outcomes with the use of migratory progenitors when compared to fibronectin adhesion assay–derived progenitors, although a direct comparison between the two cell populations is warranted. Since chondroprogenitors exhibit favorable properties for cartilage repair, efficient characterization of progenitors is imperative, to complete their phenotypic profile, so as to optimize their use in translational research for neocartilage formation.


14 May 2020 in CARTILAGE
Verified
Journal Article
Closed access
PDF file
UKUpasana Kachroo
Upasana Kachroo
SZShikha Mary Zachariah
Shikha Mary Zachariah
ATAugustine Thambaiah
Augustine Thambaiah
ATAleya Tabasum
Aleya Tabasum
ALAbel Livingston
Abel Livingston
EVElizabeth Vinod
Elizabeth Vinod
Articular chondroprogenitors, a suitable contender for cell-based therapy in cartilage repair, routinely employ fetal bovine serum (FBS) for expansion and differentiation. The possibility of transplant rejections or zoonoses transmissions raise a need for xeno-free alternatives. Use of human platelet lysate (hPL), a nutrient supplement abundant in growth factors, has not been reported for human chondroprogenitor expansion thus far. Our aim was to compare the biological profile of chondroprogenitors grown in hPL versus FBS. Chondroprogenitors were isolated from 3 osteoarthritic knee joints. Following differential fibronectin adhesion assay, passage 0 cells grown in (a) 10% FBS and (b) 10% hPL were considered for assessment of growth kinetics, surface marker expression, gene expression, and trilineage differentiation. Latent transforming growth factor–β1 (TGFβ1) levels were also measured for each culture medium used. Cellular proliferation was significantly higher in cells grown with hPL (P < 0.01). Surface marker expression was comparable except in CD-146 where hPL group had significantly higher values (P = 0.03). Comparison of mRNA expression revealed notably low values of collagen I, collagen X, aggrecan, and collagen II (P < 0.05). Trilineage differentiation was seen in both groups with higher alizarin red uptake noted in hPL. There were also significantly higher levels of latent TGFβ1 in the medium containing hPL as compared to FBS. This is the first in vitro xeno-free study to affirm that hPL can serve as an optimal growth supplement for expansion of articular chondroprogenitors, although an in-depth assessment of resident growth factors and evaluation of different dilutions of hPL is required to assess suitability for use in translational research.

1 September 2020 in Acta Histochemica
Verified
Journal Article
Closed access
EVElizabeth Vinod
Elizabeth Vinod
UKUpasana Kachroo
Upasana Kachroo
GRGrace Rebekah
Grace Rebekah
BYBijesh Yadav
Bijesh Yadav
BRBoopalan Ramasamy
Boopalan Ramasamy